Thursday 18 June 2015

Record 'fake drugs' haul worth £16m by UK agency

A spoonful of pills


Dangerous counterfeit and unlicensed medicines worth nearly £16m have been seized in a record haul by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).


Slimming pills, drugs for erectile dysfunction and cancer medicines were taken in a series of raids.


The MHRA said criminals were making money at the expense of people’s health and it was a growing problem.


Nearly 1,400 websites were closed as part of the operation.


Seven suspects are now under investigation.



The seizures were part of Operation Pangea – an international clampdown on the illegal trade in fake medicines by 115 countries.


In the UK, 6.2 million doses or medical devices were seized, worth £15.8m. Internationally, £51.6m of goods were taken.


Items seized in the UK included:


  • two million doses of erectile dysfunction drugs

  • slimming drugs – some of which can increase the risk of heart attacks and strokes

  • narcolepsy pills

  • abortion pills

  • diabetes medication

  • hair-loss drugs

  • cancer medicines, particularly for breast and prostate

  • medical devices, including fake condoms and dental laboratories

“It’s amazing to me that people will buy those types of medicines over the internet,” said the MHRA’s head of enforcement, Alastair Jeffrey.


The drugs are not always used for their medical purposes.


Breast cancer drugs are used by some body builders to reduce their breast tissue, for example.


Many packs of narcolepsy pills were seized en route to universities, where students take them for “cognitive enhancement” – to stay awake around exam time.


Mr Jeffrey added: “Criminals involved in the illegal supply of medical products through the internet aren’t interested in your health, they are interested in your money and are able to get this by selling you a potentially dangerous product or by stealing you bank details.


“To protect your health, visit your GP, get a correct diagnosis and buy medicines from a legitimate High Street or registered pharmacy which can trade online.”


It is thought that people buying the drugs are made up of those who think they are buying genuine drugs and those who are getting hold of drugs a doctor would never prescribe.


The “vast majority” of the drugs came from India and China – neither country was involved in Operation Pangea.


It is unclear what the total size of the illegal drugs market in the UK is.


The MHRA said counterfeit medicines were the greatest source of profit “across the whole criminal spectrum” but insisted the UK was “way ahead of the game”.


Mr Jeffrey said criminal gangs were moving into the field because, compared with illegal narcotics, sentencing was low.


“It’s two years, it’s not a police priority, you can use the internet as a facilitator, the risk is low and the profits are very high,” he said.


He added there were “some indications” that terrorist groups were involved in “pharmaceutical crime” in the Middle East.


Source BBC News/Health http://www.bbc.co.uk/news/health-33183330



Record 'fake drugs' haul worth £16m by UK agency

Wednesday 17 June 2015

Health and social care leaders set out next steps to transform NHS services and improve health outcomes using technology and data

nhsengland_logo


Health and social care leaders will today (17 June) unveil detailed plans to make technology work harder and faster for patients and increase transparency across more services.


Building on the successes of the last 12 months which have seen 97% of GP practices offering patients the chance to book appointments, order repeat prescriptions and view a summary of their GP records online, the plans commit to giving patients full access to their entire digital health record in real time by 2018.


A third of all ambulances now share their records digitally with A&E doctors, providing them with speedy access to critical clinical information. Under these proposals, doctors and nurses will be able to access the most up to date lifesaving information wherever they are in England by 2018 for primary, urgent and emergency care services and by 2020 for all other NHS funded services.


To drive up quality and efficiency, MyNHS will be expanded to include new information on local NHS commissioners and care homes. This step builds on the popularity of the MyNHS site, which has attracted over 200,000 visits since it was launched in September last year.


To underpin this and support the NHS on its journey to harness the power of data and technology, the National Information Board (NIB), established by the Department of Health and chaired by NHS England’s National Director for Patients and Information, Tim Kelsey, will look at the feasibility of turning the entire NHS estate into a free Wi-Fi zone.


Wi-Fi would reduce the administrative burden on doctors, nurses and care staff, currently estimated to take up to 70% of a junior doctor’s day, freeing up more time to be spent with patients.


It would also open up the possibility for ‘wearables’ to be used to monitor patients in hospital.  For example, over a fifth of patients with diabetes will have experienced a largely avoidable hypoglycemic episode whilst in hospital.  This technology can help patients and their doctors identify problems early.


Following Personalised Health and Care 2020 published by the National Information Board last November, today’s proposals mark a key moment in the journey to making technology work for patients.  Over the coming months the National Information Board and its partners will be engaging leaders and influencers from across the health and social care system to seek their views on the proposals before final publication in September.


Tim Kelsey, National Director for Patients and Information, said: “The NHS is embracing the offering of digital services to patients, with more than 55 million patients set to benefit from progress.


“As well as giving patients more choice and control, better use of technology can save money.  Letting people rebook online will help tackle the estimated £160 million that missed appointments cost the NHS each year.”


With over 50 million hits a month, NHS Choices will be the digital front door for online patient services as every citizen will soon be able to register for a GP; order prescriptions; access apps and digital tools; speak to their doctor online or via video link and view and take control of their full health record through a single online portal.


For people with long term conditions such as diabetes or asthma, devices, skin sensors or clothes which monitor health will be able to upload directly into patients’ records through this platform.


To help support the NHS’s National diabetes prevention programme, there will be a new online library of NHS approved digital tools, resources and apps that have a proven track record of effectiveness in helping people to live healthier lives. This follows the successful launch of the Mental Health Apps library on NHS Choices in March, which has since gathered over 47,000 hits.


HSCIC chief executive Andy Williams said: “The proposals announced today are a major step forward in using technology, data and information to transform the delivery of England’s health and social care services. The HSCIC looks forward to working with our partners to help local health and care organisations get the best out of these exciting new opportunities for the benefit of all patients.”


The roadmaps, which will be published in full on the National Information Board website over the coming days, are for discussion and further development with patients and the NHS and will be explored over a series of roadshows running throughout the summer. There will also be the opportunity to make comments and give feedback on the proposals via the website. The final roadmaps will be published in September at the Health and Care Innovation Expo in September.


The following proposals have also been put forward:


  • By March 2016, the NHS 111 digital service will be integrated into the NHS endorsement of third party ‘apps’ and digital services that support patients and citizens in June 2015.

  • By March 2016 an additional 150,000 citizens will be trained in digital skills.  Training resources and digital tools will be developed by August 2015.

  • By March 2016 we will extend the information available to clinicians in the Summary Care Record to include if a patient has learning disabilities or suffers from dementia. This will improve the experience for these patients and prevent them/their carers having to repeat important information each time they interact with the NHS.

To watch the livestream of the National Information Board meeting, which is taking place at the Kings Fund Digital Health Congress 2015.


Source NHS England http://www.england.nhs.uk/2015/06/17/nib/



Health and social care leaders set out next steps to transform NHS services and improve health outcomes using technology and data

Tuesday 16 June 2015

Genomics England - Successful bidders for Clinical Interpretation Services announced

Genomics England has today announced the four companies it has chosen to explore working with on the interpretation of the genomes of the first 8,000 patients participating in the 100,000 Genomes Project.


Genomics-England-logo21


 


 


 


 


 


Genomics England continues to work with Illumina and are also expanding their partnership to explore a variety of bioinformatic challenges around sequencing and clinical interpretation.


Genomics England launched a ‘bake off’ for annotation and interpretation in the Spring of 2014 to determine the quality of offerings around the world.  The ‘bake off’ attracted 28 participants, each of whom was sent the genomes of 15 rare disease trio samples and 10 cancer/normal samples and asked to interpret them.  The submitted reports were then evaluated by a team within Genomics England.


This is an important milestone for the project. We are looking to provide high quality variant interpretation to assist clinicians within the NHS and these companies will enable us to deliver this service.
A group of 10 companies passed this ‘bake off’ stage.  These companies were then invited to take part in a tender to provide interpretation services in relation to the first 8,000 patients being treated within the 100,000 Genomes Project.  The focus of the tender was whether the companies could provide an automated service with limited amounts of manual intervention in view of the establishment of the Genomics England Clinical Interpretation Partnership (GeCIP) which will provide the latter.  Genomics England wished to appoint several providers so that it could learn from a variety of approaches in this fast moving area with the ideal being to appoint four providers to each provide reports on 2,500 patients, if this could be accommodated within the budget.  For some patients interpretation reports will be provided by multiple providers to compare performance. It is expected that this phase of the project will be completed within 12 months.

Subject to passing a test phase and agreeing a contract, Genomics England will engage with Congenica and Omicia in rare disease, Nanthealth in cancer, and Wuxi Nextcode in both rare disease and cancer for this stage of the project.  Lockheed Martin in partnership with Cypher Genomics has been appointed reserve bidder.  Each of the successful suppliers will have to provide the services within the Genomics England data centre, thus ensuring that the data does not leave the data centre.  It is expected that the services will commence from 1 August, 2015.


Genomics England intends to contract for its future requirements for clinical interpretation in early 2016 when it has learnt the lessons of the current pilot phase.


Dr Augusto Rendon, Director of Bioinformatics at Genomics England commented, “This is an important milestone for the project.  We are looking to provide high quality variant interpretation to assist clinicians within the NHS and these companies will enable us to deliver this service.  We look forward to working with each of the successful companies over the next year.”


Source Genomics England http://www.genomicsengland.co.uk/news/



Genomics England - Successful bidders for Clinical Interpretation Services announced